Table of contents

Research Article

• Hepatotoxicity of antituberculosis drugs. (1 February, 1996)

  L. P. Ormerod, C. Skinner, J. Wales
• Acute lung injury following lung resection: is one lung anaesthesia to blame? (1 February, 1996)

  E. A. Williams, T. W. Evans, P. Goldstraw
• Pulmonary rehabilitation at home. (1 February, 1996)

  P. J. Wijkstra
• In vivo effects of recombinant human DNase I on sputum in patients with cystic fibrosis. (1 February, 1996)

  P. L. Shah, S. F. Scott, R. A. Knight, C. Marriott, C. Ranasinha, M. E. Hodson
• Resting energy expenditure and oxygen cost of breathing in patients with cystic fibrosis. (1 February, 1996)

  S. C. Bell, M. J. Saunders, J. S. Elborn, D. J. Shale
• Risk factors for hepatotoxicity from antituberculosis drugs: a case-control study. (1 February, 1996)

  J. N. Pande, S. P. Singh, G. C. Khilnani, S. Khilnani, R. K. Tandon
• Comparison of characteristics of patients and treatment outcome for pulmonary non-tuberculous mycobacterial infection and pulmonary tuberculosis. (1 February, 1996)

  N. Al Jarad, P. Demertzis, D. J. Jones, N. C. Barnes, R. M. Rudd, H. Gaya, J. A. Wedzicha, D. T. Hughes, D. W. Empey
• Increasing incidence of tuberculosis in the young and the elderly in Scotland. (1 February, 1996)

  J. S. Duffield, W. H. Adams, M. Anderson, A. G. Leitch
• Interleukin 10 (IL-10) regulation of tumour necrosis factor alpha (TNF-alpha) from human alveolar macrophages and peripheral blood monocytes. (1 February, 1996)

  L. Armstrong, N. Jordan, A. Millar
• Induction of interleukin 6 and interleukin 8 expression by Broncho-Vaxom (OM-85 BV) via C-Fos/serum responsive element. (1 February, 1996)

  R. Keul, M. Roth, E. Papakonstantinou, M. Nauck, A. P. Perruchoud, L. H. Block
• Priming effect of platelet activating factor on leukotriene C4 from stimulated eosinophils of asthmatic patients. (1 February, 1996)

  K. Shindo, K. Koide, Y. Hirai, M. Sumitomo, M. Fukumura
• Evidence for opioid modulation and generation of prostaglandins in sulphur dioxide (SO)2-induced bronchoconstriction. (1 February, 1996)

  P. I. Field, R. Simmul, S. C. Bell, D. H. Allen, N. Berend
• Prevalence and treatment of chronic airways obstruction in adults over the age of 45. (1 February, 1996)

  D. S. Renwick, M. J. Connolly
• Asthma, airways responsiveness and air pollution in two contrasting districts of northern England. (1 February, 1996)

  G. Devereux, T. Ayatollahi, R. Ward, C. Bromly, S. J. Bourke, S. C. Stenton, D. J. Hendrick
• Effect of altitude on spirometric parameters and the performance of peak flow meters. (1 February, 1996)

  A. J. Pollard, N. P. Mason, P. W. Barry, R. C. Pollard, D. J. Collier, R. S. Fraser, M. R. Miller, J. S. Milledge
• Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients. (1 February, 1996)

  D. Lieberman, F. Schlaeffer, I. Boldur, D. Lieberman, S. Horowitz, M. G. Friedman, M. Leiononen, O. Horovitz, E. Manor, A. Porath
• Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. (1 February, 1996)

  M. T. Kauppinen, P. Saikku, P. Kujala, E. Herva, H. Syrjälä
• Effect of chronic continuous positive airway pressure (CPAP) therapy on upper airway size in patients with sleep apnoea/hypopnoea syndrome. (1 February, 1996)

  I. L. Mortimore, P. Kochhar, N. J. Douglas
• Surgical treatment of myasthenia gravis in two major Middle East teaching hospitals: factors influencing outcome. (1 February, 1996)

  S. A. Hassantash, D. G. Ashbaugh, E. D. Verrier, R. V. Maier
• Transtracheal aspiration using rigid bronchoscopy and a rigid needle for investigating mediastinal masses. (1 February, 1996)

  M. L. Wilsher, A. M. Gurley
• Angiotensin converting enzyme (ACE) inhibitor-induced cough and substance P. (1 February, 1996)

  M. Tomaki, M. Ichinose, M. Miura, Y. Hirayama, N. Kageyama, H. Yamauchi, K. Shirato
• Assessment of oxygen supplementation during air travel. (1 February, 1996)

  D. Cramer, S. Ward, D. Geddes
• Pulmonary capillary blood volume in patients with probable pulmonary Kaposi's sarcoma. (1 February, 1996)

  F. Camus, C. de Picciotto, J. Gerbe, S. Roy, O. Bouchaud, E. Casalino, C. Perronne
• Exercise-induced asthma and cardiovascular fitness in asthmatic children. (1 February, 1996)

  B. J. Thio, A. F. Nagelkerke, A. G. Ketel, B. L. van Keeken, J. E. Dankert-Roelse
• New developments in asbestos-related pleural disease. (1 February, 1996)

  R. M. Rudd
• NO or no NO in asthma? (1 February, 1996)

  P. J. Barnes
• Pulmonary actinomycosis appearing as a "ball-in-hole" on chest radiography and bronchoscopy. (1 February, 1996)

  M. J. Hsieh, W. B. Shieh, K. S. Chen, T. J. Yu, H. P. Kuo, Y. H. Tsai
• Primary malignant melanoma of the bronchus. (1 February, 1996)

  D. J. Farrell, A. P. Kashyap, T. Ashcroft, G. N. Morritt
• Respiratory failure due to tracheobronchomalacia. (1 February, 1996)

  P. Collard, L. Freitag, M. S. Reynaert, D. O. Rodenstein, C. Francis
• Commentary: yet more to see down the bronchial tree? (1 February, 1996)

  M. R. Hetzel